Irritable Bowel Syndrome
VIDEO: ‘Light Up the Sky’ in periwinkle to raise awareness on World IBS Day
In this Healio video exclusive, Jeffrey Roberts, MS, BSc, shares details about World IBS Day, April 19, which aims to raise awareness and support for patients with irritable bowel syndrome with the theme, “Light Up the Sky for IBS.”
#IBSDilemma campaign aims to ‘break silence, challenge stigma’ during IBS Awareness Month
During Irritable Bowel Syndrome Awareness Month, an advocacy group launched the #IBSDilemma campaign to focus on the unique challenges that individuals living with this common gastrointestinal disorder may encounter in daily life.
VIDEO: ‘Dietary interventions,’ behavioral therapy pivotal to address rising tide of IBS
In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to prioritize identifying food triggers and recommending dietary interventions and behavioral therapy for patients with irritable bowel syndrome.
Providing hope for IBS patients ‘is sometimes the greatest medication’
Treating patients with irritable bowel syndrome can be a challenge for health care providers, as patients with suspected IBS often report a lengthy list of visceral and somatic symptoms that can overwhelm a busy provider.
Keys to IBS care: Understanding medical options, where they ‘might be most effective’
Results from a 2023 nationwide survey published in Gastroenterology estimated the prevalence of Rome IV irritable bowel syndrome in the U.S. climbing to 6.1% — higher than previous reports of 4.7% to 5.3%.
Healthy lifestyle behaviors associated with up to 42% lower risk for IBS
Adhering to a higher number of healthy lifestyle behaviors, such as not smoking, staying physically active and getting optimal sleep, was significantly associated with lower incidence of irritable bowel syndrome, according to data in Gut.
AGA guideline endorses FMT for recurrent C. difficile; ‘not yet advised’ for IBS, IBD
Although effective in select patients, the AGA advised against fecal microbiota-based therapies to prevent recurrent Clostridioides difficile infection in severely immunocompromised adults or to treat other gastrointestinal conditions.
AI nutrition recommendations improved anxiety, depression
Artificial intelligence-powered nutrition recommendations based on individuals’ molecular data were associated with significant improvements in anxiety, depression and more, according to studies by a company developing the technology.
The Development of GI Psychology with Megan Riehl, PsyD
In this podcast episode, Megan Riehl, PsyD, discusses symptoms and solutions in GI psychology, building educational tools for patients and physicians on GI psychology and more.
FDA: Lotronex, approved generics no longer require REMS to ensure benefits outweigh risks
FDA has eliminated the Risk Evaluation and Mitigation Strategy (REMS) programs for Lotronex (alosetron hydrochloride) and approved generics.